These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17659484)

  • 41. [Effect of silver nitrate, adenosine-5'-monophosphate and phosphoenolpyruvate on activity of extracellular fructose bisphosphatase of Acholeplasma laidlawii var. granulum strain 118].
    Skrypal' IH; Tokovenko IP; Malynovs'ka LP
    Mikrobiol Z; 2005; 67(4):28-34. PubMed ID: 16250233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In silico screening of a novel scaffold for fructose-1,6-bisphosatase (FBPase) inhibitors.
    Huang Y; Chi B; Xu Y; Song R; Wei L; Rao L; Feng L; Ren Y; Wan J
    J Mol Graph Model; 2019 Jan; 86():142-148. PubMed ID: 30366190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.
    Corbett JW
    Expert Opin Ther Pat; 2009 Jul; 19(7):943-56. PubMed ID: 19552511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase.
    Lai C; Gum RJ; Daly M; Fry EH; Hutchins C; Abad-Zapatero C; von Geldern TW
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1807-10. PubMed ID: 16446092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fructose-bisphosphatase of microorganisms].
    Skrypal' IG; Iastrebova OV
    Mikrobiol Z; 2002; 64(2):82-94. PubMed ID: 12190028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of novel allosteric site and covalent inhibitors of FBPase with potent hypoglycemic effects.
    Huang Y; Wei L; Han X; Chen H; Ren Y; Xu Y; Song R; Rao L; Su C; Peng C; Feng L; Wan J
    Eur J Med Chem; 2019 Dec; 184():111749. PubMed ID: 31589992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-based design and synthesis of novel dual-target inhibitors against cyanobacterial fructose-1,6-bisphosphate aldolase and fructose-1,6-bisphosphatase.
    Li D; Han X; Tu Q; Feng L; Wu D; Sun Y; Chen H; Li Y; Ren Y; Wan J
    J Agric Food Chem; 2013 Aug; 61(31):7453-61. PubMed ID: 23889687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors.
    Dang Q; Kasibhatla SR; Jiang T; Fan K; Liu Y; Taplin F; Schulz W; Cashion DK; Reddy KR; van Poelje PD; Fujitaki JM; Potter SC; Erion MD
    J Med Chem; 2008 Jul; 51(14):4331-9. PubMed ID: 18570362
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-based drug design of tricyclic 8H-indeno[1,2-d][1,3]thiazoles as potent FBPase inhibitors.
    Tsukada T; Takahashi M; Takemoto T; Kanno O; Yamane T; Kawamura S; Nishi T
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1004-7. PubMed ID: 20045638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural analysis of human glutamine:fructose-6-phosphate amidotransferase, a key regulator in type 2 diabetes.
    Nakaishi Y; Bando M; Shimizu H; Watanabe K; Goto F; Tsuge H; Kondo K; Komatsu M
    FEBS Lett; 2009 Jan; 583(1):163-7. PubMed ID: 19059404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subcellular localization of liver FBPase is modulated by metabolic conditions.
    Yáñez AJ; Garcia-Rocha M; Bertinat R; Droppelmann C; Concha II; Guinovart JJ; Slebe JC
    FEBS Lett; 2004 Nov; 577(1-2):154-8. PubMed ID: 15527777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A library of novel allosteric inhibitors against fructose 1,6-bisphosphatase.
    Heng S; Gryncel KR; Kantrowitz ER
    Bioorg Med Chem; 2009 Jun; 17(11):3916-22. PubMed ID: 19419876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of coumarin on hepatic key enzymes of glucose metabolism in chemical induced type 2 diabetic rats.
    Pari L; Rajarajeswari N
    Chem Biol Interact; 2009 Oct; 181(3):292-6. PubMed ID: 19647726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relative binding affinities of fructose-1,6-bisphosphatase inhibitors calculated using a quantum mechanics-based free energy perturbation method.
    Reddy MR; Erion MD
    J Am Chem Soc; 2007 Aug; 129(30):9296-7. PubMed ID: 17616196
    [No Abstract]   [Full Text] [Related]  

  • 56. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M; Lam S
    Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evolutionary chemistry approach toward finding novel inhibitors of the type 2 diabetes target glucose-6-phosphate translocase.
    Bräuer S; Almstetter M; Antuch W; Behnke D; Taube R; Furer P; Hess S
    J Comb Chem; 2005; 7(2):218-26. PubMed ID: 15762749
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The origin of the high sensitivity of muscle fructose 1,6-bisphosphatase towards AMP.
    Rakus D; Maciaszczyk E; Wawrzycka D; Ułaszewski S; Eschrich K; Dzugaj A
    FEBS Lett; 2005 Oct; 579(25):5577-81. PubMed ID: 16213487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Incretins in the treatment of diabetes].
    Bulum T; Smircić-Duvnjak L; Car N; Metelko Z
    Lijec Vjesn; 2008; 130(7-8):195-200. PubMed ID: 18979908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of the New Covalent Allosteric Binding Site of Fructose-1,6-bisphosphatase with Disulfiram Derivatives toward Glucose Reduction.
    Huang Y; Xu Y; Song R; Ni S; Liu J; Xu Y; Ren Y; Rao L; Wang Y; Wei L; Feng L; Su C; Peng C; Li J; Wan J
    J Med Chem; 2020 Jun; 63(11):6238-6247. PubMed ID: 32375478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.